This could be explained by the higher uptake of [18F]PSMA-1007 in healthy tissues such as the liver, heart, and glands as well as the less pronounced absolute difference in tumor uptake between both PSMA tracers in low PSMA expressing tumors. The gene discussed is FOLH1; the disease is neoplasm.